BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26384667)

  • 1. Modelling the Impact of Atherosclerosis on Drug Release and Distribution from Coronary Stents.
    McKittrick CM; Kennedy S; Oldroyd KG; McGinty S; McCormick C
    Ann Biomed Eng; 2016 Feb; 44(2):477-87. PubMed ID: 26384667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mechanistic model for drug release from PLGA-based drug eluting stent: A computational study.
    Naghipoor J; Rabczuk T
    Comput Biol Med; 2017 Nov; 90():15-22. PubMed ID: 28917119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge.
    Borovac JA; D'Amario D; Vergallo R; Porto I; Bisignani A; Galli M; Annibali G; Montone RA; Leone AM; Niccoli G; Crea F
    Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):105-116. PubMed ID: 30285099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release mechanism and parameter estimation in drug-eluting stent systems: analytical solutions of drug release and tissue transport.
    McGinty S; McKee S; McCormick C; Wheel M
    Math Med Biol; 2015 Jun; 32(2):163-86. PubMed ID: 24463960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
    Stettler R; Dijkstra J; Räber L; Torii R; Zhang YJ; Karanasos A; Lui S; Crake T; Hamshere S; Garcia-Garcia HM; Tenekecioglu E; Ozkor M; Windecker S; Serruys PW; Regar E; Mathur A; Bourantas CV
    EuroIntervention; 2018 Feb; 13(15):e1831-e1840. PubMed ID: 28606888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the influence of atherosclerosis on drug coated balloon therapy using computational modelling.
    Anbalakan K; Toh HW; Ang HY; Buist ML; Leo HL
    Eur J Pharm Biopharm; 2021 Jan; 158():72-82. PubMed ID: 33075477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical modeling of drug dynamics induced by eluting stents in the coronary multi-layered curved domain.
    d'Errico M; Sammarco P; Vairo G
    Math Biosci; 2015 Sep; 267():79-96. PubMed ID: 26162517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the ultrathin Orsiro Hybrid sirolimus-eluting stent with contemporary drug-eluting stents: A meta-analysis of randomized controlled trials.
    Lipinski MJ; Forrestal BJ; Iantorno M; Torguson R; Waksman R
    Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):5-11. PubMed ID: 29221958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of proximal drug eluting stent (DES) on distal bare metal stent (BMS) in multi-stent implantation strategies in coronary arteries.
    Sun A; Wang Z; Fan Z; Tian X; Zhan F; Deng X; Liu X
    Med Eng Phys; 2015 Sep; 37(9):840-4. PubMed ID: 26149391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term benefits of drug-eluting stents compared to bare metal stents even in treatment for large coronary arteries.
    Yoshida T; Sakata K; Nitta Y; Taguchi T; Kaku B; Katsuda S; Shimojima M; Gamou T; Nakahashi T; Konno T; Kawashiri MA; Yamagishi M; Hayashi K
    Heart Vessels; 2016 May; 31(5):635-42. PubMed ID: 25758470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of late-acquired stent malapposition of drug eluting stents with second generation permanent and biodegradable polymer coatings-A prospective, randomized comparison using optical coherence tomography.
    Roth C; Gangl C; Dalos D; Delle-Karth G; Neunteufl T; Berger R
    J Interv Cardiol; 2018 Dec; 31(6):780-791. PubMed ID: 30479028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of Drug Eluting Stents performance in human atherosclerotic artery through in silico modeling.
    Loukas VS; Karanasiou GS; Pleouras D; Kyriakidis S; Sakellarios AI; Semertzioglou A; Michalis LK; Fotiadis DI
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():5433-5436. PubMed ID: 34892355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Implantable Artificial Atherosclerotic Plaque as a Novel Approach for Drug Transport Studies on Drug-Eluting Stents.
    Razzi F; Lovrak M; Gruzdyte D; Den Hartog Y; Duncker DJ; van Esch JH; van Steijn V; van Beusekom HMM
    Adv Healthc Mater; 2022 Mar; 11(6):e2101570. PubMed ID: 34865315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of plaque eccentricity on blood hemodynamics and drug release in a stented artery.
    Ferreira JA; Gonçalves L; Naghipoor J; de Oliveira P; Rabczuk T
    Med Eng Phys; 2018 Oct; 60():47-60. PubMed ID: 30111489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Endothelial Dysfunction in Coronary Arteries with Bare Metal and 2
    Akiyama Y; Matoba T; Katsuki S; Takase S; Nakashiro S; Nakano Y; Noma K; Tsutsui H
    J Atheroscler Thromb; 2022 Mar; 29(3):379-392. PubMed ID: 33612554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?
    Weiss AJ; Lorente-Ros M; Correa A; Barman N; Tamis-Holland JE
    Curr Atheroscler Rep; 2022 Sep; 24(9):731-744. PubMed ID: 35821187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography.
    Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Tanaka K; Matsumoto T; Kawamoto H; Yamada Y; Amano S; Watanabe Y; Warisawa T; Sato T; Mitomo S; Kurita N; Ishiguro H; Hozawa K; Tsukahara T; Motosuke M; Bezerra HG; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Mar; 230():284-292. PubMed ID: 28065691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.